Vemurafenib April 13, 2017 Vemurafenib Trade Name Orphan Indication Langerhans’ cell histiocytosis EU Market Approval EU EU Designation Date 2016-05-30 00:00:00 Sponsor Groupe d'étude des histiocytoses
